Similar articles

• Appropriate outpatient treatment of acute bacterial exacerbations of chronic bronchitis.

  Martinez FJ, Anzueto A. Martinez FJ, et al. Am J Med. 2005 Jul;118 Suppl 7A:39S-44S. doi: 10.1016/j.amjmed.2005.05.012. Am J Med. 2005. PMID: 15993676 Review.
• Conclusions. Role of the oral Beta-lactams in the treatment of exacerbations of chronic bronchitis: critical analysis and therapeutics recommendations.

  Blasi F, Concia E, Mazzei T, Moretti AM, Nicoletti G, Novelli A, Tempera G; GIARIR. Blasi F, et al. J Chemother. 2010 Nov;22 Suppl 1:25-8. J Chemother. 2010. PMID: 21097390 Review. English, Italian. No abstract available.
• [Antibiotic resistance of some Pseudomonas aeruginosa isolates].

  Matinca D, Vancea D, Boboş C, Serban O. Matinca D, et al. Bacteriol Virusol Parazitol Epidemiol. 2003 Apr-Sep;48(2-3):157-61. Bacteriol Virusol Parazitol Epidemiol. 2003. PMID: 15341333 Romanian. No abstract available.
• Acute exacerbations of chronic bronchitis: new developments concerning microbiology and pathophysiology--impact on approaches to risk stratification and therapy.

  Sethi S, Murphy TF. Sethi S, et al. Infect Dis Clin North Am. 2004 Dec;18(4):861-82, ix. doi: 10.1016/j.idc.2004.07.006. Infect Dis Clin North Am. 2004. PMID: 15555829 Review.
• Study entry microbiology in patients with acute bacterial exacerbation of chronic bronchitis in a clinical trial stratifying by disease severity.

  Kahn JB, Khashab M, Ambruzs M. Kahn JB, et al. Curr Med Res Opin. 2007 Jan;23(1):1-7. doi: 10.1185/030079907X159515. Curr Med Res Opin. 2007. PMID: 17261234 Clinical Trial.